NIH Data Access Committee

NIH Data Access Committee
Name	NIH Data Access Committee
Formation	21st century
Type	Advisory body
Headquarters	Bethesda, Maryland
Parent organization	National Institutes of Health

Contents

NIH Data Access Committee The NIH Data Access Committee is an advisory review body within the National Institutes of Health system that evaluates requests for controlled-access biomedical and genomic datasets. It coordinates policies across repositories and institutes such as the National Human Genome Research Institute, National Cancer Institute, and National Institute of Allergy and Infectious Diseases, and interfaces with federal frameworks including the Health Insurance Portability and Accountability Act and the 21st Century Cures Act. The committee’s remit spans interagency collaborations with entities like the Centers for Disease Control and Prevention, Food and Drug Administration, and international partners including the World Health Organization.

Overview

The committee adjudicates data access requests for repositories hosted by the National Library of Medicine, Database of Genotypes and Phenotypes, and domain-specific archives such as the All of Us Research Program and the Genotype-Tissue Expression Project. It applies criteria informed by guidance from the Common Rule, the Belmont Report, and policies promulgated by the Office for Human Research Protections. Stakeholders interacting with the committee include principal investigators from institutions like Harvard University, Johns Hopkins University, Stanford University, and consortia such as the Human Genome Project and the Cancer Genome Atlas.

The committee emerged amid debates following high-profile projects including the Human Genome Project, the International HapMap Project, and the expansion of controlled-access models after incidents involving re-identification in datasets associated with researchers at MIT, Harvard Medical School, and Broad Institute. Regulatory milestones influencing its formation include actions by the National Academies of Sciences, Engineering, and Medicine, reports from the President's Council of Advisors on Science and Technology, and legislative changes like provisions in the Consolidated Appropriations Act. The committee’s procedures evolved alongside initiatives from the National Science Foundation, the Global Alliance for Genomics and Health, and the European Bioinformatics Institute.

Primary functions include reviewing data use certifications, assessing applicant qualifications from institutions such as University of California, San Francisco, Yale University, and University College London, and enforcing data use limitations aligned with consents approved by institutional review boards like those at Columbia University and University of Pennsylvania. The committee adjudicates disputes, issues administrative determinations, and advises directors of institutes including the National Institute of Mental Health and the National Institute on Aging. It also contributes to policy development alongside offices such as the NIH Office of Data Science Strategy and the NIH Office of the Director.

Membership typically comprises scientists, bioinformaticians, ethicists, legal experts, and patient-representatives drawn from organizations such as American Medical Association, Association of American Medical Colleges, and advocacy groups like Alzheimer's Association and American Cancer Society. Governance follows NIH advisory committee norms comparable to those of the National Advisory Council on Biomedical Imaging and Bioengineering and is subject to Federal Advisory Committee Act requirements. Chairs and members historically have included investigators affiliated with institutions such as Massachusetts General Hospital, Scripps Research, and Mayo Clinic.

Decisions are guided by data access agreements, data use limitation codes, and controlled-access models similar to those used by the European Genome-phenome Archive, dbGaP, and the Sequence Read Archive. The committee evaluates project plans, data security measures referencing standards from National Institute of Standards and Technology, and provenance documentation often linked to repositories at European Molecular Biology Laboratory and cloud platforms used by Amazon Web Services, Google Cloud, and Microsoft Azure. It applies sanctions, revocations, and audits informed by precedent from cases involving institutions such as University of Washington and Cornell University.

The committee coordinates with program offices and advisory groups across NIH, including the All of Us Research Program leadership, the Center for Scientific Review, and the Clinical Center. It reports findings and recommendations to institute directors, participates in interagency working groups with Office of Science and Technology Policy, and collaborates with external standard-setting bodies such as the Global Alliance for Genomics and Health and the International Committee of Medical Journal Editors.

Critiques have arisen over transparency, pace of review, and consistency—echoing disputes seen in debates involving the Human Connectome Project, the ENCODE Project, and data-sharing controversies at institutions including Wellcome Trust Sanger Institute and Cold Spring Harbor Laboratory. Civil liberties groups like the American Civil Liberties Union and privacy scholars from universities such as University of California, Berkeley have questioned controls after re-identification studies by researchers at NYU and Carnegie Mellon University. Policy scholars from the Brookings Institution and RAND Corporation have debated trade-offs between open science initiatives advocated by the Howard Hughes Medical Institute and protections emphasized by patient groups such as Susan G. Komen.